Log In
Print
BCIQ
Print
Print this Print this
 

Xamiol, calcipotriene/betamethasone dipropionate (Taclonex topical suspension)

Also known as: Taclonex Scalp (Taclonex Scalp gel) (LEO 80185)

  Manage Alerts
Collapse Summary General Information
Company Leo Pharma A/S
DescriptionTopical suspension containing 0.005% calcipotriene plus 0.064% betamethasone dipropionate
Molecular Target Glucocorticoid receptor (GCCR)
Mechanism of ActionGlucocorticoid receptor agonist
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationPsoriasis
Indication DetailsTreat scalp and body psoriasis vulgaris
Regulatory Designation
Partner Kyowa Hakko Kirin Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today